Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis

Hebah Alhajeri 1, Fatemah Abutiban 2, Wasl Al-Adsani 3, Adel Al-Awadhi 4, Ali Aldei 5, Ahmad AlEnizi 2, Naser Alhadhood 6, Adeeba Al-Herz 5, Waleed Alkandari 6, Ahmad Dehrab 7, Aqeel A Muhanna Ghanem 3, Eman Hasan 5, Sawsan Hayat 3, Khulood Saleh 6, Hoda Tarakmeh 3, Yaser Ali 

Affiliations

01 September 2019

-

doi: 10.1007/s00296-019-04372-y

Abstract

The Kuwait Association of Rheumatology (KAR) aimed to develop a set of recommendations for the treatment of patients with rheumatoid arthritis (RA), tailored to the unique patient population and healthcare system of Kuwait. Each recommendation was developed based on expert opinion and evaluation of clinical practice guidelines from other international and national rheumatology societies. Online surveys were conducted to collate feedback on each KAR member's level of agreement (LoA) with definitions of disease-/treatment-related terms used and the draft recommendations. Definitions/recommendations achieving a pre-defined cut-off value of ≥ 70% agreement were accepted for inclusion. Remaining statements were discussed and revised at a face-to-face meeting, with further modifications until consensus was reached. A final online survey was used to collect feedback on each KAR member's LoA with the final set of recommendation statements on a scale of 0 (complete disagreement) to 10 (complete agreement). Group consensus was achieved on 66 recommendation statements, including 3 overarching principles addressing the pharmacological treatment and management of RA. Recommendations focused on treatment of early RA, established RA, patients with high-risk comorbidities, women during pregnancy and breastfeeding, and screening and treatment of opportunistic infections. The KAR 2018 Treatment Recommendations for RA reported here are based on a synthesis of other national/international guidelines, supporting literature, and expert consensus considering the Kuwaiti healthcare system and RA patient population. These recommendations aim to inform the clinical decisions of rheumatologists treating patients in Kuwait, and to promote best practices, enhance alignment and improve the treatment experience for patients.

Keywords: Anti-TNF; DMARDs (biologic); DMARDs (synthetic); Early rheumatoid arthritis; Infections; Pregnancy; Rheumatoid arthritis; Treatment; Tumor necrosis factor-alpha.

Similar articles

2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

Louthrenoo W, Kasitanon N, Katchamart W, Aiewruengsurat D, Chevaisrakul P, Chiowchanwisawakit P, Dechanuwong P, Hanvivadhanakul P, Mahakkanukrauh A, Manavathongchai S, Muangchan C, Narongroeknawin P, Phumethum V, Siripaitoon B, Suesuwan A, Suwannaroj S, Uea-Areewongsa P, Ukritchon S, Asavatanabodee P, Koolvisoot A, Nanagara R, Totemchokchyakarn K, Nuntirooj K, Kitumnuaypong T.Int J Rheum Dis. 2017 Sep;20(9):1166-1184. doi: 10.1111/1756-185X.13130. Epub 2017 Jul 21.PMID: 28730640 Review.

Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.

Katchamart W, Narongroeknawin P, Chevaisrakul P, Dechanuwong P, Mahakkanukrauh A, Kasitanon N, Pakchotanon R, Sumethkul K, Ueareewongsa P, Ukritchon S, Bhurihirun T, Duangkum K, Intapiboon P, Intongkam S, Jangsombatsiri W, Jatuworapruk K, Kositpesat N, Leungroongroj P, Lomarat W, Petcharat C, Sittivutworapant S, Suebmee P, Tantayakom P, Tipsing W, Asavatanabodee P, Chiowchanwisawakit P, Foocharoen C, Koolvisoot A, Louthrenoo W, Siripaitoon B, Totemchokchyakarn K, Kitumnuaypong T; Thai Rheumatism Association.Int J Rheum Dis. 2017 Sep;20(9):1142-1165. doi: 10.1111/1756-185X.12905. Epub 2016 Jul 25.PMID: 27452207 Review.

2018 update of the APLAR recommendations for treatment of rheumatoid arthritis.

Lau CS, Chia F, Dans L, Harrison A, Hsieh TY, Jain R, Jung SM, Kishimoto M, Kumar A, Leong KP, Li Z, Lichauco JJ, Louthrenoo W, Luo SF, Mu R, Nash P, Ng CT, Suryana B, Wijaya LK, Yeap SS.Int J Rheum Dis. 2019 Mar;22(3):357-375. doi: 10.1111/1756-185X.13513. Epub 2019 Feb 27.PMID: 30809944

Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.

Bombardier C, Hazlewood GS, Akhavan P, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, Gardam MA, Askling J, Bykerk V; Canadian Rheumatology Association.J Rheumatol. 2012 Aug;39(8):1583-602. doi: 10.3899/jrheum.120165. Epub 2012 Jun 15.PMID: 22707613

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR, Furst DE, Parks D, Kavanaugh A, O'Dell J, King C, Leong A, Matteson EL, Schousboe JT, Drevlow B, Ginsberg S, Grober J, St Clair EW, Tindall E, Miller AS, McAlindon T; American College of Rheumatology.Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25. doi: 10.1002/acr.22783. Epub 2015 Nov 6.PMID: 26545825 Review.

Cited by

What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines.

Conley B, Bunzli S, Bullen J, O'Brien P, Persaud J, Gunatillake T, Nikpour M, Grainger R, Barnabe C, Lin I.Clin Rheumatol. 2023 Sep;42(9):2267-2278. doi: 10.1007/s10067-023-06654-0. Epub 2023 Jun 9.PMID: 37291382 Free PMC article. Review.

Consistency of recommendations for pharmacotherapy of rheumatoid arthritis.

Hu Y, Han Y, Ma Y, Fan S, Wang X, Fu X, Hu X, Luo X, Ma Y, Xun Y, Yang N, Wen C, Cao W, Song X, Chen Y.Front Pharmacol. 2022 Oct 25;13:967787. doi: 10.3389/fphar.2022.967787. eCollection 2022.PMID: 36386133 Free PMC article.

The burden of rheumatoid arthritis in the Middle East and North Africa region, 1990-2019.

Mousavi SE, Nejadghaderi SA, Khabbazi A, Alizadeh M, Sullman MJM, Kaufman JS, Collins GS, Safiri S.Sci Rep. 2022 Nov 11;12(1):19297. doi: 10.1038/s41598-022-22310-0.PMID: 36369238 Free PMC article.

Protein DEK and DTA Aptamers: Insight Into the Interaction Mechanisms and the Computational Aptamer Design.

Dai L, Zhang J, Wang X, Yang X, Pan F, Yang L, Zhao Y.Front Mol Biosci. 2022 Jul 19;9:946480. doi: 10.3389/fmolb.2022.946480. eCollection 2022.PMID: 35928230 Free PMC article.

Effectiveness and safety of aerobic exercise for rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.

Ye H, Weng H, Xu Y, Wang L, Wang Q, Xu G.BMC Sports Sci Med Rehabil. 2022 Feb 5;14(1):17. doi: 10.1186/s13102-022-00408-2.PMID: 35123568 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Rheumatology (Oxford). 2002 Dec;41(12):1346-56 - PubMed
  2.  
    1. J Rheumatol. 2004 Apr;31(4):645-8 - PubMed
  3.  
    1. Eur J Gastroenterol Hepatol. 2004 Sep;16(9):891-6 - PubMed
  4.  
    1. Transfusion. 2005 Dec;45(12):1973-80 - PubMed
  5.  
    1. Arthritis Rheum. 2006 Dec 15;55(6):864-72 - PubMed
  6.  
    1. Ann Intern Med. 2007 Mar 20;146(6):406-15 - PubMed
  7.  
    1. Br J Dermatol. 2007 Sep;157(3):587-90 - PubMed
  8.  
    1. Intern Med J. 2007 Oct;37(10):705-12 - PubMed
  9.  
    1. BMC Infect Dis. 2008 Jan 07;8:3 - PubMed
  10.  
    1. Ann Rheum Dis. 2009 Jan;68(1):25-32 - PubMed
  11.  
    1. Rheumatology (Oxford). 2008 Apr;47(4):507-13 - PubMed
  12.  
    1. Hepatology. 2009 May;49(5 Suppl):S35-44 - PubMed
  13.  
    1. Arthritis Rheum. 2009 Aug;60(8):2262-71 - PubMed
  14.  
    1. MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25 - PubMed
  15.  
    1. Ann Rheum Dis. 2011 Oct;70(10):1719-25 - PubMed
  16.  
    1. Arthritis Res Ther. 2011 Jun 29;13(3):223 - PubMed
  17.  
    1. J Rheumatol. 2012 Aug;39(8):1559-82 - PubMed
  18.  
    1. Int J Rheumatol. 2011;2011:845496 - PubMed
  19.  
    1. Arthritis Care Res (Hoboken). 2012 May;64(5):625-39 - PubMed
  20.  
    1. Ann Intern Med. 2012 May 15;156(10):743-5 - PubMed
  21.  
    1. Ann Rheum Dis. 2013 Jan;72(1):72-8 - PubMed
  22.  
    1. J Rheumatol. 2012 Aug;39(8):1583-602 - PubMed
  23.  
    1. Ann Rheum Dis. 2012 Nov;71(11):1757-60 - PubMed
  24.  
    1. Infect Drug Resist. 2012;5:163-73 - PubMed
  25.  
    1. Am J Manag Care. 2012 Dec;18(13 Suppl):S295-302 - PubMed
  26.  
    1. Gut. 2013 Nov;62(11):1523-8 - PubMed
  27.  
    1. Ann Rheum Dis. 2014 Jan;73(1):3-5 - PubMed
  28.  
    1. World J Gastroenterol. 2013 Nov 28;19(44):7867-73 - PubMed
  29.  
    1. Ann Rheum Dis. 2015 Jun;74(6):1037-44 - PubMed
  30.  
    1. Ann Rheum Dis. 2014 Jul;73(7):1316-22 - PubMed
  31.  
    1. Ther Adv Musculoskelet Dis. 2014 Oct;6(5):169-84 - PubMed
  32.  
    1. Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7 - PubMed
  33.  
    1. Dig Dis. 2014;32 Suppl 1:116-21 - PubMed
  34.  
    1. Dig Dis. 2014;32 Suppl 1:122-7 - PubMed
  35.  
    1. Clin Exp Rheumatol. 2015 Mar-Apr;33(2):272-8 - PubMed
  36.  
    1. BMC Musculoskelet Disord. 2015 May 06;16:107 - PubMed
  37.  
    1. Arthritis Res Ther. 2015 May 22;17:136 - PubMed
  38.  
    1. Rheumatology (Oxford). 2015 Oct;54(10):1858-66 - PubMed
  39.  
    1. Arthritis Rheumatol. 2016 Jan;68(1):56-66 - PubMed
  40.  
    1. Int J Rheum Dis. 2015 Sep;18(7):685-713 - PubMed
  41.  
    1. Arthritis Rheumatol. 2016 Jan;68(1):1-26 - PubMed
  42.  
    1. Rheumatology (Oxford). 2016 Sep;55(9):1693-7 - PubMed
  43.  
    1. Ann Rheum Dis. 2016 May;75(5):795-810 - PubMed
  44.  
    1. Ann Rheum Dis. 2016 Aug;75(8):1428-37 - PubMed
  45.  
    1. Rheumatology (Oxford). 2017 May 1;56(5):689-697 - PubMed
  46.  
    1. Eur J Rheumatol. 2016 Mar;3(1):25-28 - PubMed
  47.  
    1. Ann Rheum Dis. 2017 Jun;76(6):948-959 - PubMed
  48.  
    1. Ann Rheum Dis. 2017 Jul;76(7):1253-1262 - PubMed
  49.  
    1. Ann Rheum Dis. 2017 Jun;76(6):960-977 - PubMed
  50.  
    1. Curr Opin Rheumatol. 2017 May;29(3):260-268 - PubMed
  51.  
    1. J Rheumatol. 2018 Jan;45(1):14-21 - PubMed
  52.  
    1. Rheumatol Ther. 2017 Dec;4(2):247-261 - PubMed
  53.  
    1. Hepatology. 2018 Apr;67(4):1560-1599 - PubMed
  54.  
    1. Clin Exp Rheumatol. 2018 Jul-Aug;36(4):658-667 - PubMed
  55.  
    1. JAMA. 2018 Oct 2;320(13):1360-1372 - PubMed
  56.  
    1. Clin Rheumatol. 2019 Mar;38(3):949-954 - PubMed
  57.  
    1. Clin Exp Rheumatol. 2019 Jul-Aug;37(4):694-704 - PubMed
  58.  
    1. Clin Pharmacokinet. 1996 Mar;30(3):194-210 - PubMed

Page Navigation